Form 4 for GILD Gilead Sciences
Accepted 2023-07-25 00:00:00 ET · period of report 2023-07-24 · accession 0001127602-23-021245 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-25 | 2023-07-24 | GILD | Mercier Johanna | Chief Commercial Off | F - Tax | $77.66 | -3,174 | 48.3K | -6% | -$246.5K |
| D | 2023-07-25 | 2023-07-24 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +7,505 | 51.5K | +17% | — |
| D | 2023-07-25 | 2023-07-24 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | — | -7,505 | 45.4K | -14% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-24 | F | D | 3,174 | $77.66 | 48,326 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-24 | M | A | 7,505 | — | 51,500 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Derivative | Restricted Stock Unit | 2023-07-24 | M | D | 7,505 | — | 45,447 | D | — · — to — | 7,505 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested. |